CRISPR Therapeutics AG(CRSP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CRSP CRISPR Therapeutics AG

休市中 09-19 16:00:00 EDT

62.32

-0.62

-0.99%

盘后62.90

+0.58+0.93%

19:59 EDT

最高64.18	最低62.27	成交量523.47万
今开63.18	昨收62.94	日振幅3.03%
总市值56.68亿	流通市值56.42亿	总股本9,095万
成交额3.29亿	换手率5.78%	流通股本9,053万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CRSP","market":"US","secType":"STK","nameCN":"CRISPR Therapeutics AG","latestPrice":62.32,"timestamp":1758312000000,"preClose":62.94,"halted":0,"volume":5234673,"hourTrading":{"tag":"盘后","latestPrice":62.9,"preClose":62.32,"latestTime":"19:59 EDT","volume":598428,"amount":37298309.7045,"timestamp":1758326391066},"delay":0,"floatShares":90533000,"shares":90950423,"eps":-5.443695,"marketStatus":"休市中","change":-0.62,"latestTime":"09-19 16:00:00 EDT","open":63.18,"high":64.1784,"low":62.27,"amount":329154510.79791,"amplitude":0.030321,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.443695,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1758528000000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1476849600000,"exchange":"NASDAQ","adjPreClose":62.94,"preHourTrading":{"tag":"盘前","latestPrice":63.2,"preClose":62.94,"latestTime":"09:29 EDT","volume":11328,"amount":717444.5614080001,"timestamp":1758288599512},"postHourTrading":{"tag":"盘后","latestPrice":62.9,"preClose":62.32,"latestTime":"19:59 EDT","volume":598428,"amount":37298309.7045,"timestamp":1758326391066},"volumeRatio":1.8034000973675677,"impliedVol":0.6556,"impliedVolPercentile":0.624},"requestUrl":"/m/hq/s/CRSP","defaultTab":"news","newsList":[{"id":"2568170287","title":"小摩看好CRISPR(CRSP.US)基因编辑管线潜力 首予“增持”评级目标价70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2568170287","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568170287?lang=zh_cn&edition=full","pubTime":"2025-09-19 09:01","pubTimestamp":1758243687,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，摩根大通首次对CRISPR Therapeutics给出“增持”评级，并强调该公司凭借其管线潜力在基因编辑领域占据独特优势。该行分析师Brian Cheng在报告中指出，随着公司投资组合接近多个关键发展拐点，CRISPR Therapeutics值得投资者重新关注，目标价设定为70美元。摩根大通在报告中进一步阐释：“我们相信，CRISPR 通过在自身免疫细胞疗法与体内心血管赛道之间取得平衡，已制定正确战略并储备充足资源，可规避部分基因编辑同行所面临的困境。”","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1347083.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["CRSP"],"gpt_icon":0},{"id":"2568400073","title":"Crispr Therapeutics Ag盘中异动 早盘股价大涨5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568400073","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568400073?lang=zh_cn&edition=full","pubTime":"2025-09-18 21:53","pubTimestamp":1758203629,"startTime":"0","endTime":"0","summary":"北京时间2025年09月18日21时53分，Crispr Therapeutics Ag股票出现异动，股价快速拉升5.28%。Crispr Therapeutics Ag股票所在的生物技术行业中，整体涨幅为0.67%。Crispr Therapeutics Ag公司简介：CRISPR Therapeutics是一家基因编辑公司，专注于开发基于Crispr/Cas9的疗法。Crispr/Cas9代表成簇的规则间隔短回文重复序列/Crispr相关蛋白9，是精确改变基因组DNA特定序列的革命性技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091821534995369f21&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","BK4585","BK4611","BK4588","BK4007","LU1861558580.USD","LU1861559042.SGD","CRSP","BK4556","LENZ"],"gpt_icon":0},{"id":"2568447196","title":"JPMorgan Initiates Coverage on CRISPR Therapeutics With Overweight Rating, $70 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2568447196","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568447196?lang=zh_cn&edition=full","pubTime":"2025-09-18 19:34","pubTimestamp":1758195282,"startTime":"0","endTime":"0","summary":"CRISPR Therapeutics (CRSP) has an average rating of overweight and mean price target of $78.35, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research fro","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"摩根大通首次对CRISPR Therapeutics给予跑赢大盘评级，目标价70美元","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CRSP"],"gpt_icon":0},{"id":"2559489809","title":"CRISPR Therapeutics（CRSP）涨幅迅速扩大至3.4%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2559489809","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559489809?lang=zh_cn&edition=full","pubTime":"2025-08-16 00:42","pubTimestamp":1755276177,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","LENZ","BK4539","BK4007","BK4556","LU1861558580.USD","LU1861559042.SGD","BK4585","BK4588","CRSP","BK4611"],"gpt_icon":0},{"id":"2558925516","title":"Crispr Therapeutics Ag8月11日成交额为1.13亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558925516","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558925516?lang=zh_cn&edition=full","pubTime":"2025-08-12 09:50","pubTimestamp":1754963408,"startTime":"0","endTime":"0","summary":"美东时间2025年8月11日，Crispr Therapeutics Ag成交额为1.13亿美元，成交额较昨日增加26.24%，当日成交量为201.43万股。Crispr Therapeutics Ag于2025年8月11日涨0.75%，报55.41美元，该股过去5个交易日跌7.01%，年初至今涨40.78%，过去60日涨55.65%。Crispr/Cas9是成簇的规则间隔短回文重复序列/Crispr相关蛋白9的缩写，是精确改变基因组DNA特定序列的革命性技术。Crispr第一个获批的药物是Casgevy，它是与Vertex制药公司合作开发的，主要针对镰状细胞病和输血依赖型β-地中海贫血，这两种疾病的医疗需求尚未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812095015a482f4ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4139","CRSP","LENZ","BK4539","BK4556","BK4588","LU1861559042.SGD","LU1861558580.USD","BK4611","BK4007"],"gpt_icon":0},{"id":"2558101503","title":"Crispr Therapeutics Ag8月8日成交额为8941.56万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558101503","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558101503?lang=zh_cn&edition=full","pubTime":"2025-08-09 09:50","pubTimestamp":1754704212,"startTime":"0","endTime":"0","summary":"美东时间2025年8月8日，Crispr Therapeutics Ag成交额为8941.56万美元，成交额较昨日减少15.59%，当日成交量为162.34万股。Crispr Therapeutics Ag于2025年8月8日跌1.72%，报55.0美元，该股过去5个交易日跌1.94%，年初至今涨39.74%，过去60日涨47.77%。Crispr/Cas9是成簇的规则间隔短回文重复序列/Crispr相关蛋白9的缩写，是精确改变基因组DNA特定序列的革命性技术。Crispr第一个获批的药物是Casgevy，它是与Vertex制药公司合作开发的，主要针对镰状细胞病和输血依赖型β-地中海贫血，这两种疾病的医疗需求尚未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809095015a6dbe694&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4585","BK4556","BK4539","LENZ","BK4007","CRSP","LU1861558580.USD","LU1861559042.SGD","BK4588","BK4611"],"gpt_icon":0},{"id":"2558769605","title":"Truist Securities Adjusts Price Target on CRISPR Therapeutics to $100 From $120, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2558769605","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558769605?lang=zh_cn&edition=full","pubTime":"2025-08-09 00:04","pubTimestamp":1754669076,"startTime":"0","endTime":"0","summary":"CRISPR Therapeutics (CRSP) has an average rating of overweight and mean price target of $78.60, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research fro","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"Truist Securities将CRISPR Therapeutics目标价从120美元调整至100美元，维持买入评级","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LENZ","CRSP"],"gpt_icon":0},{"id":"2557515004","title":"Crispr Therapeutics Ag8月7日成交额为1.06亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557515004","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557515004?lang=zh_cn&edition=full","pubTime":"2025-08-08 09:48","pubTimestamp":1754617735,"startTime":"0","endTime":"0","summary":"美东时间2025年8月7日，Crispr Therapeutics Ag成交额为1.06亿美元，成交额较昨日减少21.96%，当日成交量为190.70万股。Crispr Therapeutics Ag于2025年8月7日跌0.67%，报55.96美元，该股过去5个交易日跌0.53%，年初至今涨42.17%，过去60日涨48.87%。Crispr/Cas9是成簇的规则间隔短回文重复序列/Crispr相关蛋白9的缩写，是精确改变基因组DNA特定序列的革命性技术。Crispr第一个获批的药物是Casgevy，它是与Vertex制药公司合作开发的，主要针对镰状细胞病和输血依赖型β-地中海贫血，这两种疾病的医疗需求尚未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808094904a6d9dc5a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4539","BK4611","LU1861558580.USD","BK4588","BK4556","LENZ","BK4007","CRSP","LU1861559042.SGD","BK4139"],"gpt_icon":0},{"id":"2557584165","title":"Crispr Therapeutics Ag8月6日成交额为1.36亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557584165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557584165?lang=zh_cn&edition=full","pubTime":"2025-08-07 09:47","pubTimestamp":1754531242,"startTime":"0","endTime":"0","summary":"美东时间2025年8月6日，Crispr Therapeutics Ag成交额为1.36亿美元，成交额较昨日减少46.36%，当日成交量为243.16万股。Crispr Therapeutics Ag于2025年8月6日涨1.35%，报56.34美元，该股过去5个交易日跌2.32%，年初至今涨43.14%，过去60日涨58.17%。Crispr/Cas9是成簇的规则间隔短回文重复序列/Crispr相关蛋白9的缩写，是精确改变基因组DNA特定序列的革命性技术。Crispr第一个获批的药物是Casgevy，它是与Vertex制药公司合作开发的，主要针对镰状细胞病和输血依赖型β-地中海贫血，这两种疾病的医疗需求尚未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807094727a6d79eac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4139","LU1861558580.USD","CRSP","LENZ","BK4539","BK4556","BK4585","LU1861559042.SGD","BK4007","BK4611"],"gpt_icon":0},{"id":"1135796688","title":"CRISPR Therapeutics夜盘上涨，获“木头姐”增持及机构“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=1135796688","media":"老虎资讯综合","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135796688?lang=zh_cn&edition=full","pubTime":"2025-08-06 10:25","pubTimestamp":1754447112,"startTime":"0","endTime":"0","summary":"这家基因编辑公司的股价上涨势头强劲。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRSP"],"gpt_icon":0},{"id":"2557349572","title":"Crispr Therapeutics Ag8月5日成交额为2.53亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557349572","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557349572?lang=zh_cn&edition=full","pubTime":"2025-08-06 09:45","pubTimestamp":1754444738,"startTime":"0","endTime":"0","summary":"美东时间2025年8月5日，Crispr Therapeutics Ag成交额为2.53亿美元，成交额较昨日增加27.45%，当日成交量为454.33万股。Crispr Therapeutics Ag于2025年8月5日跌6.71%，报55.59美元，该股过去5个交易日跌5.81%，年初至今涨41.23%，过去60日涨53.82%。Crispr/Cas9是成簇的规则间隔短回文重复序列/Crispr相关蛋白9的缩写，是精确改变基因组DNA特定序列的革命性技术。Crispr第一个获批的药物是Casgevy，它是与Vertex制药公司合作开发的，主要针对镰状细胞病和输血依赖型β-地中海贫血，这两种疾病的医疗需求尚未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806094545a6d57aa7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","LENZ","BK4139","BK4007","BK4588","LU1861558580.USD","LU1861559042.SGD","BK4539","CRSP","BK4611","BK4585"],"gpt_icon":0},{"id":"2557739592","title":"RBC Raises Price Target on CRISPR Therapeutics to $42 From $38, Keeps Sector Perform, Speculative Risk","url":"https://stock-news.laohu8.com/highlight/detail?id=2557739592","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557739592?lang=zh_cn&edition=full","pubTime":"2025-08-05 19:24","pubTimestamp":1754393083,"startTime":"0","endTime":"0","summary":"CRISPR Therapeutics (CRSP) has an average rating of overweight and mean price target of $78.46, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research fro","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"加拿大皇家银行将CRISPR Therapeutics的目标价从38美元上调至42美元，保持行业表现和投机风险","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LENZ","CRSP"],"gpt_icon":0},{"id":"2557935657","title":"Crispr Therapeutics Ag8月4日成交额为1.99亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557935657","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557935657?lang=zh_cn&edition=full","pubTime":"2025-08-05 09:44","pubTimestamp":1754358292,"startTime":"0","endTime":"0","summary":"美东时间2025年8月4日，Crispr Therapeutics Ag成交额为1.99亿美元，成交额较昨日增加19.00%，当日成交量为340.11万股。Crispr Therapeutics Ag于2025年8月4日涨6.24%，报59.59美元，该股过去5个交易日跌6.53%，年初至今涨51.4%，过去60日涨73.99%。Crispr/Cas9是成簇的规则间隔短回文重复序列/Crispr相关蛋白9的缩写，是精确改变基因组DNA特定序列的革命性技术。Crispr第一个获批的药物是Casgevy，它是与Vertex制药公司合作开发的，主要针对镰状细胞病和输血依赖型β-地中海贫血，这两种疾病的医疗需求尚未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805094502a6d3647c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4539","BK4007","BK4556","LU1861558580.USD","LU1861559042.SGD","BK4585","BK4588","CRSP","BK4611"],"gpt_icon":0},{"id":"2557334959","title":"CORRECTION: CRISPR Therapeutics Q2 Adj. EPS $(1.29) Beats $(1.47) Estimate, Sales $892.000K Miss $6.255M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2557334959","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557334959?lang=zh_cn&edition=full","pubTime":"2025-08-05 05:05","pubTimestamp":1754341523,"startTime":"0","endTime":"0","summary":"CRISPR Therapeutics (NASDAQ:CRSP) reported quarterly losses of $(1.29) per share which beat the analyst consensus estimate of $(1.47) by 11.95 percent. This is a 13.42 percent increase over losses of $(1.49) per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"更正：CRISPR Therapeutics第二季度调整后每股收益$(1.29)超出$(1.47)预期，销售额$892,000 K低于预期625.5万美元","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/46841596/correction-crispr-therapeutics-q2-adj-eps-1-29-beats-1-47-estimate-sales-892-000k-miss-6-255m-estim","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRSP","LENZ"],"gpt_icon":1},{"id":"2557331468","title":"CRISPR Therapeutics Q2 EPS $(2.40) Down From $(1.49) YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2557331468","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557331468?lang=zh_cn&edition=full","pubTime":"2025-08-05 04:30","pubTimestamp":1754339419,"startTime":"0","endTime":"0","summary":"CRISPR Therapeutics Q2 EPS $(2.40) Down From $(1.49) YoY","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"CRISPR Therapeutics第二季度每股收益(2.40)美元，低于同比(1.49)美元","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/46840452/crispr-therapeutics-q2-eps-2-40-down-from-1-49-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRSP","LENZ"],"gpt_icon":0},{"id":"2556842310","title":"Crispr Therapeutics Ag8月1日成交额为1.67亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556842310","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556842310?lang=zh_cn&edition=full","pubTime":"2025-08-02 09:44","pubTimestamp":1754099057,"startTime":"0","endTime":"0","summary":"美东时间2025年8月1日，Crispr Therapeutics Ag成交额为1.67亿美元，成交额较昨日减少10.82%，当日成交量为299.23万股。Crispr Therapeutics Ag于2025年8月1日跌0.3%，报56.09美元，该股过去5个交易日跌13.39%，年初至今涨42.51%，过去60日涨69.15%。Crispr/Cas9是成簇的规则间隔短回文重复序列/Crispr相关蛋白9的缩写，是精确改变基因组DNA特定序列的革命性技术。Crispr第一个获批的药物是Casgevy，它是与Vertex制药公司合作开发的，主要针对镰状细胞病和输血依赖型β-地中海贫血，这两种疾病的医疗需求尚未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802094421a6cea5b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRSP","LU1861559042.SGD","BK4007","BK4539","LU1861558580.USD","BK4556","BK4585","BK4611","LENZ","BK4588","BK4139"],"gpt_icon":0},{"id":"2556688018","title":"Crispr Therapeutics Ag7月31日成交额为1.87亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556688018","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556688018?lang=zh_cn&edition=full","pubTime":"2025-08-01 09:44","pubTimestamp":1754012652,"startTime":"0","endTime":"0","summary":"美东时间2025年7月31日，Crispr Therapeutics Ag成交额为1.87亿美元，成交额较昨日减少2.25%，当日成交量为326.72万股。Crispr Therapeutics Ag于2025年7月31日跌2.46%，报56.26美元，该股过去5个交易日跌14.83%，年初至今涨42.94%，过去60日涨49.55%。Crispr/Cas9是成簇的规则间隔短回文重复序列/Crispr相关蛋白9的缩写，是精确改变基因组DNA特定序列的革命性技术。Crispr第一个获批的药物是Casgevy，它是与Vertex制药公司合作开发的，主要针对镰状细胞病和输血依赖型β-地中海贫血，这两种疾病的医疗需求尚未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801094413a46e9b10&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4611","BK4539","CRSP","LENZ","LU1861559042.SGD","BK4585","BK4556","BK4588","BK4139","LU1861558580.USD","BK4007"],"gpt_icon":0},{"id":"2555095851","title":"Crispr Therapeutics Ag7月29日成交额为2.52亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555095851","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555095851?lang=zh_cn&edition=full","pubTime":"2025-07-30 09:47","pubTimestamp":1753840070,"startTime":"0","endTime":"0","summary":"美东时间2025年7月29日，Crispr Therapeutics Ag成交额为2.52亿美元，成交额较昨日增加132.35%，当日成交量为420.63万股。Crispr Therapeutics Ag于2025年7月29日跌7.42%，报59.02美元，该股过去5个交易日跌10.48%，年初至今涨49.95%，过去60日涨56.43%。Crispr/Cas9是成簇的规则间隔短回文重复序列/Crispr相关蛋白9的缩写，是精确改变基因组DNA特定序列的革命性技术。Crispr第一个获批的药物是Casgevy，它是与Vertex制药公司合作开发的，主要针对镰状细胞病和输血依赖型β-地中海贫血，这两种疾病的医疗需求尚未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730094756a46a8ae5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4611","LU1861558580.USD","LU1861559042.SGD","BK4139","BK4585","BK4539","BK4588","LENZ","BK4007","BK4556","CRSP"],"gpt_icon":0},{"id":"2554718665","title":"Crispr Therapeutics Ag7月25日成交额为1.90亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554718665","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554718665?lang=zh_cn&edition=full","pubTime":"2025-07-26 09:47","pubTimestamp":1753494424,"startTime":"0","endTime":"0","summary":"美东时间2025年7月25日，Crispr Therapeutics Ag成交额为1.90亿美元，成交额较昨日减少3.09%，当日成交量为291.50万股。Crispr Therapeutics Ag于2025年7月25日跌1.97%，报64.76美元，该股过去5个交易日跌0.57%，年初至今涨64.53%，过去60日涨73.16%。Crispr/Cas9是成簇的规则间隔短回文重复序列/Crispr相关蛋白9的缩写，是精确改变基因组DNA特定序列的革命性技术。Crispr第一个获批的药物是Casgevy，它是与Vertex制药公司合作开发的，主要针对镰状细胞病和输血依赖型β-地中海贫血，这两种疾病的医疗需求尚未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250726094705a6c27314&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRSP","BK4139","BK4611","LENZ","LU1861558580.USD","BK4588","LU1861559042.SGD","BK4556","BK4539","BK4585","BK4007"],"gpt_icon":1},{"id":"2553224024","title":"Crispr Therapeutics Ag7月23日成交额为2.58亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553224024","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553224024?lang=zh_cn&edition=full","pubTime":"2025-07-24 09:44","pubTimestamp":1753321455,"startTime":"0","endTime":"0","summary":"美东时间2025年7月23日，Crispr Therapeutics Ag成交额为2.58亿美元，成交额较昨日减少5.19%，当日成交量为379.06万股。Crispr Therapeutics Ag于2025年7月23日涨3.35%，报68.14美元，该股过去5个交易日涨23.58%，年初至今涨73.12%，过去60日涨78.05%。Crispr/Cas9是成簇的规则间隔短回文重复序列/Crispr相关蛋白9的缩写，是精确改变基因组DNA特定序列的革命性技术。Crispr第一个获批的药物是Casgevy，它是与Vertex制药公司合作开发的，主要针对镰状细胞病和输血依赖型β-地中海贫血，这两种疾病的医疗需求尚未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724094421a6be8b0e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4611","CRSP","BK4588","BK4139","BK4556","LU1861559042.SGD","BK4539","LENZ","LU1861558580.USD","BK4007","BK4585"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.crisprtx.com","stockEarnings":[{"period":"1week","weight":0.1077},{"period":"1month","weight":0.1743},{"period":"3month","weight":0.4084},{"period":"6month","weight":0.5119},{"period":"1year","weight":0.2592},{"period":"ytd","weight":0.5833}],"compareEarnings":[{"period":"1week","weight":0.0096},{"period":"1month","weight":0.0401},{"period":"3month","weight":0.1168},{"period":"6month","weight":0.1768},{"period":"1year","weight":0.1624},{"period":"ytd","weight":0.1324}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"CRISPR Therapeutics AG作为一家瑞士股份公司在Inception Genomics AG名下于2013年10月31日注册成立。他们是一家领先的基因研究的公司，专注于CRISPR/Cas9的疗法发展。 CRISPR/ Cas9代表集群，定期相互间隔短回文重复（CRISPR）相关蛋白9，是改变基因的编排，基因组DNA的特定序列过程中的一项革命性的技术。他们正在应用此技术通过破坏，纠正或调节与疾病相关的基因来治疗广泛的稀有或常见的疾病。他们最先进的项目是针对β-地中海贫血和镰状细胞病，这种病症的治疗需要两个满足高医疗需求的血红蛋白。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.086437},{"month":2,"riseRate":0.666667,"avgChangeRate":0.085839},{"month":3,"riseRate":0.222222,"avgChangeRate":-0.093679},{"month":4,"riseRate":0.666667,"avgChangeRate":-0.004907},{"month":5,"riseRate":0.555556,"avgChangeRate":0.088862},{"month":6,"riseRate":0.777778,"avgChangeRate":0.125525},{"month":7,"riseRate":0.777778,"avgChangeRate":0.040401},{"month":8,"riseRate":0.444444,"avgChangeRate":-0.01221},{"month":9,"riseRate":0.222222,"avgChangeRate":-0.063175},{"month":10,"riseRate":0.375,"avgChangeRate":-0.049057},{"month":11,"riseRate":0.777778,"avgChangeRate":0.210307},{"month":12,"riseRate":0.222222,"avgChangeRate":-0.070626}],"exchange":"NASDAQ","name":"CRISPR Therapeutics AG","nameEN":"CRISPR Therapeutics AG"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.3","shortVersion":"4.35.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CRISPR Therapeutics AG(CRSP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供CRISPR Therapeutics AG(CRSP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"CRISPR Therapeutics AG,CRSP,CRISPR Therapeutics AG股票,CRISPR Therapeutics AG股票老虎,CRISPR Therapeutics AG股票老虎国际,CRISPR Therapeutics AG行情,CRISPR Therapeutics AG股票行情,CRISPR Therapeutics AG股价,CRISPR Therapeutics AG股市,CRISPR Therapeutics AG股票价格,CRISPR Therapeutics AG股票交易,CRISPR Therapeutics AG股票购买,CRISPR Therapeutics AG股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CRISPR Therapeutics AG(CRSP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供CRISPR Therapeutics AG(CRSP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}